Full coverage: medtech

The Galway medtech start-up is preparing trials for its device for diabetics in the US and is planning a funding round in the coming months.

The Waterford medtech company has brought on a new investor in US firm Five Arrows and is eyeing a major R&D and manufacturing expansion stateside.

Despite a dangerously low share price, the Bray company has remained acquisitive, buying up companies that have brought it into new verticals.

Imelda Lambkin heads up the Disruptive Technologies Innovation Fund, tasked with backing cutting-edge tech projects in Ireland. She talks to The Currency about the fund’s mission and its future.

The US-listed company, which owns a medical device plant in Galway, moved its incorporation – and tax residence – from Switzerland to Ireland this week.

The deal sees the Stockholm-listed animal health group acquire the Meath-based company for an initial €84m with a further €60m dependent on targets.

AQF Medical makes specialist packaging for the medical device sector and has been picked up by the Nasdaq-listed firm. The deal means another exit for Irish private equity firm Renatus Capital Partners.

The Limerick-based and Toronto-listed firm builds software for the life sciences sector but said its business is dependent on a “relatively small number of customers”.

Podimetrics filed a complaint against the Galway medtech start-up in the US, claiming its device for scanning diabetics' feet violates its patents.

Partner Niall McEvoy explains why the firm is scouting out more early-stage start-ups in the medtech and health space and discusses the state of Irish VC investing.